Clustering data with hclust algorithm for (Study ST001795)

Reversed phase NEGATIVE ION MODE (Analysis AN002916)
MetaboliteStructureF1F2F3
FA (22:5)ME4168630.751.241.03
Aeruginopeptin 917S-CME4168161.010.851.12
[FA (22:4)] 7Z_10Z_13Z_16Z-docosatetraenoic acidME4168380.980.951.07
CholesterolsulfateME4168071.040.791.15
FA(16:1)ME4168581.041.020.94
beta-TocotrienolME4167171.050.041.79
FA hydroxy(18:0)ME4167311.170.321.44
FA methyl(16:1)ME4168820.841.410.80
1-Hexadecanoyl-2-(9Z-octadecenoyl)-sn-glycero-3-cytidine-5^- diphosphateME4167161.08NA0.92
Cer(t18:0/h24:0)ME4168530.861.101.05
bafilomycin A1ME4169050.561.860.68
CGS 7181ME4168720.981.190.85
FA hydroxy (18:2)ME4169210.402.410.35
CitrateME4167861.300.611.04
(4Z_7Z_10Z_13Z_16Z_19Z)-Docosahexaenoic acid ethyl esterME4168710.941.210.87
Cyanidin 3-(6-acetylgalactoside)ME4168171.010.851.12
DecosideME4167100.90NA1.08
DocosahexaenoicacidME4167891.080.711.18
Dodecanoic acidME4167211.430.081.39
FA (20:0)ME4167611.190.531.23
FA hydroxy(20:1)ME4168021.080.761.13
3-O-(6^-O-(9Z_12Z_15Z-octadecatrienoyl)-beta-D-glucopyranosyl)-campest-5-en-3beta-olME4168491.070.950.97
Docosanoic acidME4167791.100.661.21
[FA (34:2)] 1-octadecyl-11E-hexadecenoateME4169060.441.960.71
2-heptaprenyl-3-methyl-6-methoxy-1_4-benzoquinolME4167881.130.691.14
3-O-(6^-O-(11Z_14Z_17Z-eicosatrienoyl)-beta-D-glucopyranosyl)-campest-5-en-3beta-olME4168401.140.870.98
Arachidyl palmitoleateME4169070.381.910.68
FA (18:1)ME4167591.240.511.19
[FA (24:0)] 15Z-tetracosenoic acidME4168600.941.120.96
FA (20:4)ME4168091.000.831.15
3alpha_7alpha_12alpha-Trihydroxy-5beta-cholestan-26-alME4169230.172.900.15
FA (20:2)ME4168800.791.420.84
FA (19:1)ME4168750.831.330.88
FA methyl(18:0)ME4168960.611.690.78
FA (18:3)ME4168760.891.300.84
FA hydroxy(20:3)ME4168561.860.560.53
CDP-DG(36:2)ME4167121.10NA0.90
FA (17:0)ME4168650.871.200.96
FA hydroxy(18:2)ME4168191.010.871.11
16-feruloyloxypalmitateME4167571.270.491.19
FA (22:1)ME4168281.050.881.06
1-18:0-2-18:3-monogalactosyldiacylglycerolME4168370.960.951.08
FA (18:2)ME4169020.671.750.66
[FA (26:0)] hexacosanoic acidME4167961.080.741.14
FA dimethyl(20:3)ME4167421.150.411.37
FA (20:3)ME4168330.910.971.12
FA (14:1) tetradecenoic acidME4167931.130.711.13
4Z_7Z_10Z_13Z_16Z_19Z_22Z_25Z-octacosaoctaenoic acidME4167131.02NA0.99
FA hydroxy(12:0) dodecanoic acidME4167521.210.481.25
FA (23:1)ME4168740.831.320.88
FA (20:1)ME4168291.110.861.02
FA (16:3)ME4168351.120.870.99
FA hydroxy(18:1)]ME4168550.901.091.02
FA hydroxy(20:4)ME4168542.380.280.26
FA (16:2)ME4168850.821.440.78
FA hydroxy(22:0)ME4167811.140.651.17
FA (18:4)ME4168391.080.901.01
FA methyl(14:0)ME4168790.801.380.86
[FA oxo(14:0)] 3-oxo-tetradecanoic acidME4167691.200.561.19
Avermectin B2b monosaccharideME4168141.130.791.06
BilirubinME4168460.871.031.09
1_2-di-S-octyl-1_2-dimercapto-3-propanolME4168041.300.680.99
FA hydroxy(18:1)ME4168980.911.490.65

Factors:

F1Treatment:Celecoxib_HFD
F2Treatment:CFD
F3Treatment:HFD
Data matrix
  logo